Imunic的CEO将在2月的几次重要会议上讨论该公司的疾病治疗管道。 Immunic's CEO will discuss the company’s disease treatment pipeline at several key February conferences.

一家侧重于发展慢性炎症和自发性免疫疾病的治疗方法的生物技术公司 -- -- 免疫公司 -- -- 将于2月参加若干重要会议。 Immunic, a biotech firm focused on developing treatments for chronic inflammatory and autoimmune diseases, will participate in several key conferences in February. 包括首席执行官丹尼尔·维特在内的执行官将讨论该公司对克罗恩病和多发性硬化症等疾病的小型分子疗法管道。 Executives including CEO Daniel Vitt will discuss the company's pipeline of small molecule therapies for conditions like Crohn's disease and multiple sclerosis. 会议包括BIO首席执行官和投资者会议、Oppenheimer卫生保健生命科学会议和ACTRIMS论坛。 Conferences include the BIO CEO & Investor Conference, Oppenheimer Healthcare Life Sciences Conference, and ACTRIMS Forum.